Form 4: Vertex Pharmaceuticals Executive Amit Sachdev Reports Stock Transactions
SEC Form 4 Filing
Amit Sachdev, EVP Chief Patient & External Affairs Officer at Vertex Pharmaceuticals, reports the disposition and acquisition of company stock.
Summary
- On February 23, 2024, Amit Sachdev disposed of 2,469 shares of Vertex Pharmaceuticals common stock at a price of $431.79.
- On February 26, 2024, Sachdev sold 3,004 shares of common stock at $425.7 per share.
- Following these transactions, Sachdev directly owns 55,325 shares of common stock.
- Sachdev also indirectly owns 882 shares through a 401(k) and 6,565 shares held in trust.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions. There is no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is a common practice among publicly traded companies. It provides transparency into the trading activities of insiders.
Stakeholder Impact
- The stock transactions by a company executive may be of interest to shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/09/2023 | Date of entry into Rule 10b5-1 trading plan |
| 02/23/2024 | Date of disposition of 2,469 shares of common stock |
| 02/26/2024 | Date of sale of 3,004 shares of common stock |
| 02/27/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.